TABLE II.

Physical Performance and Pain Outcomes by Study Groups (N = 84) Adjusted and Unadjusted for Pain

WeekFSDT treated (number of repetitions)FSDT untreated
(number of repetitions)
30-SCST
(number of rises)
6MWT (inches)SCT
(seconds)
BFR 80% LOP014.5 (5.2)16.6 (4.6)11.5 (3.19)21,727 (3,589)4.62 (2.61)
317.0 (5.4)18.4 (4.9)12.9 (3.37)23,630 (3,641)4.22 (1.70)*
618.7 (5.9)19.4 (5.1)14.0 (4.05)23,614 (3,927)4.21 (1.78)
919.5 (7.1)21.3 (5.9)14.8 (5.00)23,156 (3,578)3.99 (1.07)
BFR 20 mmHg of LOP012.0 (4.9)14.3 (4.8)10.8 (2.60)22,059 (3,270)4.35 (0.88)
313.3 (6.0)15.8 (4.7)11.5 (3.36)22,730 (3,635)4.75 (2.58)*
615.9 (5.1)17.7 (6.6)12.6 (3.45)23,745 (4,057)4.08 (0.96)
916.9 (6.0)18.7 (6.5)13.9 (3.54)23,573 (4,021)3.76 (0.68)
Mixed-effects models F testa
Unadjusted
TimeF(1,217) = 37.9 (P < .0001)F(1,203) = 25.7 (P < .0001)F(1,206) = 101 (P < .0001)F(1,194) = 16.5 (P < .0001)F(1,184) = 8.7 (P = .004)
GroupF(1,120) = 2.9
P = .09)
F(1,111) = 3.8
P = .05)
F(1,112) = 1.33
P = .25)
F(1,111) = 0.00
(P = .98)
F(1,104) = 0.03
(P = .87)
t×gF(1,201) = 1.17
(P = .28)
F(1,203) = 0.02 (P = .89)F(1,206) = 0.24 (P = .62)F(1,194) = 0.06 (P = .81)F(1,184) = 0.23 (P = .63)
Adjusted for pain at time of testing
TimeF(1,205) = 55.6 (P < .0001)F(1,203) = 76.5 (P < .0001)F(1,215) = 62.2 (P < .0001)F(1,204) = 6.1 (P = .01)F(1,189) = 2.6 (P = .11)
GroupF(1,114) = 5.6
(P = .02)
F(1,111) = 3.6
(P = .06)
F(1,115) = 0.72
(P = .40)
F(1,114) = 0.19
(P = .66)
F(1,106) = 0.67
(P = .42)
t×gF(1,197) = 0.40
(P = .53)
F(1,202) = 0.007
(P = .98)
F(1,206) = 0.84
(P = .36)
F(1,192) = 0.01 (P = .91)F(1,182) = 1.12 (P = .29)
WeekFSDT treated (number of repetitions)FSDT untreated
(number of repetitions)
30-SCST
(number of rises)
6MWT (inches)SCT
(seconds)
BFR 80% LOP014.5 (5.2)16.6 (4.6)11.5 (3.19)21,727 (3,589)4.62 (2.61)
317.0 (5.4)18.4 (4.9)12.9 (3.37)23,630 (3,641)4.22 (1.70)*
618.7 (5.9)19.4 (5.1)14.0 (4.05)23,614 (3,927)4.21 (1.78)
919.5 (7.1)21.3 (5.9)14.8 (5.00)23,156 (3,578)3.99 (1.07)
BFR 20 mmHg of LOP012.0 (4.9)14.3 (4.8)10.8 (2.60)22,059 (3,270)4.35 (0.88)
313.3 (6.0)15.8 (4.7)11.5 (3.36)22,730 (3,635)4.75 (2.58)*
615.9 (5.1)17.7 (6.6)12.6 (3.45)23,745 (4,057)4.08 (0.96)
916.9 (6.0)18.7 (6.5)13.9 (3.54)23,573 (4,021)3.76 (0.68)
Mixed-effects models F testa
Unadjusted
TimeF(1,217) = 37.9 (P < .0001)F(1,203) = 25.7 (P < .0001)F(1,206) = 101 (P < .0001)F(1,194) = 16.5 (P < .0001)F(1,184) = 8.7 (P = .004)
GroupF(1,120) = 2.9
P = .09)
F(1,111) = 3.8
P = .05)
F(1,112) = 1.33
P = .25)
F(1,111) = 0.00
(P = .98)
F(1,104) = 0.03
(P = .87)
t×gF(1,201) = 1.17
(P = .28)
F(1,203) = 0.02 (P = .89)F(1,206) = 0.24 (P = .62)F(1,194) = 0.06 (P = .81)F(1,184) = 0.23 (P = .63)
Adjusted for pain at time of testing
TimeF(1,205) = 55.6 (P < .0001)F(1,203) = 76.5 (P < .0001)F(1,215) = 62.2 (P < .0001)F(1,204) = 6.1 (P = .01)F(1,189) = 2.6 (P = .11)
GroupF(1,114) = 5.6
(P = .02)
F(1,111) = 3.6
(P = .06)
F(1,115) = 0.72
(P = .40)
F(1,114) = 0.19
(P = .66)
F(1,106) = 0.67
(P = .42)
t×gF(1,197) = 0.40
(P = .53)
F(1,202) = 0.007
(P = .98)
F(1,206) = 0.84
(P = .36)
F(1,192) = 0.01 (P = .91)F(1,182) = 1.12 (P = .29)

Values are mean ± SD except where indicated.

*

P < .05; comparing 80% LOP BFR group to 20 mmHg BFR group at each time point from a mixed-effects model with time as a factor.

a

Mixed-effects models with time as continuous using a type III ANOVA table with Satterthwaite’s method. The F value, degrees of freedom, and corresponding P-values are presented. Time effect is for overall change during the study for all participants. Group tests whether there is a difference between the group means across all measurements. t×g tests whether change over time differs between at least one of the treatment groups and PT.

Abbreviations: 6MWT, 6-minute walk test; 30-SCST, 30-second chair stand test; BFR, blood flow restriction; FSDT, forward step-down test; LOP, limb occlusion pressure; NMES, neuromuscular electrical stimulation; SCT, timed stair climb test; SD, standard deviation.

TABLE II.

Physical Performance and Pain Outcomes by Study Groups (N = 84) Adjusted and Unadjusted for Pain

WeekFSDT treated (number of repetitions)FSDT untreated
(number of repetitions)
30-SCST
(number of rises)
6MWT (inches)SCT
(seconds)
BFR 80% LOP014.5 (5.2)16.6 (4.6)11.5 (3.19)21,727 (3,589)4.62 (2.61)
317.0 (5.4)18.4 (4.9)12.9 (3.37)23,630 (3,641)4.22 (1.70)*
618.7 (5.9)19.4 (5.1)14.0 (4.05)23,614 (3,927)4.21 (1.78)
919.5 (7.1)21.3 (5.9)14.8 (5.00)23,156 (3,578)3.99 (1.07)
BFR 20 mmHg of LOP012.0 (4.9)14.3 (4.8)10.8 (2.60)22,059 (3,270)4.35 (0.88)
313.3 (6.0)15.8 (4.7)11.5 (3.36)22,730 (3,635)4.75 (2.58)*
615.9 (5.1)17.7 (6.6)12.6 (3.45)23,745 (4,057)4.08 (0.96)
916.9 (6.0)18.7 (6.5)13.9 (3.54)23,573 (4,021)3.76 (0.68)
Mixed-effects models F testa
Unadjusted
TimeF(1,217) = 37.9 (P < .0001)F(1,203) = 25.7 (P < .0001)F(1,206) = 101 (P < .0001)F(1,194) = 16.5 (P < .0001)F(1,184) = 8.7 (P = .004)
GroupF(1,120) = 2.9
P = .09)
F(1,111) = 3.8
P = .05)
F(1,112) = 1.33
P = .25)
F(1,111) = 0.00
(P = .98)
F(1,104) = 0.03
(P = .87)
t×gF(1,201) = 1.17
(P = .28)
F(1,203) = 0.02 (P = .89)F(1,206) = 0.24 (P = .62)F(1,194) = 0.06 (P = .81)F(1,184) = 0.23 (P = .63)
Adjusted for pain at time of testing
TimeF(1,205) = 55.6 (P < .0001)F(1,203) = 76.5 (P < .0001)F(1,215) = 62.2 (P < .0001)F(1,204) = 6.1 (P = .01)F(1,189) = 2.6 (P = .11)
GroupF(1,114) = 5.6
(P = .02)
F(1,111) = 3.6
(P = .06)
F(1,115) = 0.72
(P = .40)
F(1,114) = 0.19
(P = .66)
F(1,106) = 0.67
(P = .42)
t×gF(1,197) = 0.40
(P = .53)
F(1,202) = 0.007
(P = .98)
F(1,206) = 0.84
(P = .36)
F(1,192) = 0.01 (P = .91)F(1,182) = 1.12 (P = .29)
WeekFSDT treated (number of repetitions)FSDT untreated
(number of repetitions)
30-SCST
(number of rises)
6MWT (inches)SCT
(seconds)
BFR 80% LOP014.5 (5.2)16.6 (4.6)11.5 (3.19)21,727 (3,589)4.62 (2.61)
317.0 (5.4)18.4 (4.9)12.9 (3.37)23,630 (3,641)4.22 (1.70)*
618.7 (5.9)19.4 (5.1)14.0 (4.05)23,614 (3,927)4.21 (1.78)
919.5 (7.1)21.3 (5.9)14.8 (5.00)23,156 (3,578)3.99 (1.07)
BFR 20 mmHg of LOP012.0 (4.9)14.3 (4.8)10.8 (2.60)22,059 (3,270)4.35 (0.88)
313.3 (6.0)15.8 (4.7)11.5 (3.36)22,730 (3,635)4.75 (2.58)*
615.9 (5.1)17.7 (6.6)12.6 (3.45)23,745 (4,057)4.08 (0.96)
916.9 (6.0)18.7 (6.5)13.9 (3.54)23,573 (4,021)3.76 (0.68)
Mixed-effects models F testa
Unadjusted
TimeF(1,217) = 37.9 (P < .0001)F(1,203) = 25.7 (P < .0001)F(1,206) = 101 (P < .0001)F(1,194) = 16.5 (P < .0001)F(1,184) = 8.7 (P = .004)
GroupF(1,120) = 2.9
P = .09)
F(1,111) = 3.8
P = .05)
F(1,112) = 1.33
P = .25)
F(1,111) = 0.00
(P = .98)
F(1,104) = 0.03
(P = .87)
t×gF(1,201) = 1.17
(P = .28)
F(1,203) = 0.02 (P = .89)F(1,206) = 0.24 (P = .62)F(1,194) = 0.06 (P = .81)F(1,184) = 0.23 (P = .63)
Adjusted for pain at time of testing
TimeF(1,205) = 55.6 (P < .0001)F(1,203) = 76.5 (P < .0001)F(1,215) = 62.2 (P < .0001)F(1,204) = 6.1 (P = .01)F(1,189) = 2.6 (P = .11)
GroupF(1,114) = 5.6
(P = .02)
F(1,111) = 3.6
(P = .06)
F(1,115) = 0.72
(P = .40)
F(1,114) = 0.19
(P = .66)
F(1,106) = 0.67
(P = .42)
t×gF(1,197) = 0.40
(P = .53)
F(1,202) = 0.007
(P = .98)
F(1,206) = 0.84
(P = .36)
F(1,192) = 0.01 (P = .91)F(1,182) = 1.12 (P = .29)

Values are mean ± SD except where indicated.

*

P < .05; comparing 80% LOP BFR group to 20 mmHg BFR group at each time point from a mixed-effects model with time as a factor.

a

Mixed-effects models with time as continuous using a type III ANOVA table with Satterthwaite’s method. The F value, degrees of freedom, and corresponding P-values are presented. Time effect is for overall change during the study for all participants. Group tests whether there is a difference between the group means across all measurements. t×g tests whether change over time differs between at least one of the treatment groups and PT.

Abbreviations: 6MWT, 6-minute walk test; 30-SCST, 30-second chair stand test; BFR, blood flow restriction; FSDT, forward step-down test; LOP, limb occlusion pressure; NMES, neuromuscular electrical stimulation; SCT, timed stair climb test; SD, standard deviation.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close